BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)

25 filings reported holding BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2018.
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,723,414 shares of 6,235,531 outstanding shares and own 59.71% of the company stock.
Largest 10 shareholders include FMR LLC (1,666,666 shares), Artemis Investment Management LLP (1,238,495 shares), VANGUARD GROUP INC (300,798 shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (298,400 shares), Point72 Asset Management, L.P. (65,809 shares), MILLENNIUM MANAGEMENT LLC (45,796 shares), Prudence Asset Management Ltd (30,000 shares), Marshall Wace North America L.P. (18,907 shares), BlackRock Inc. (14,957 shares), and Dean Capital Investments Management, LLC (13,259 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.